Serina Therapeutics, Inc.
SER
$5.65
$0.152.73%
AMEX
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -79.67% | 91.77% | -311.44% | -303.06% | -687.18% |
| Total Depreciation and Amortization | 2.11% | 82.35% | 115.56% | 43.57% | 122.22% |
| Total Amortization of Deferred Charges | -95.14% | 1,368.18% | -- | -- | -- |
| Total Other Non-Cash Items | -954.17% | -309.17% | 61.39% | 72.60% | 113.44% |
| Change in Net Operating Assets | 142.44% | -1,152.96% | -4,395.06% | -2,887.62% | -1,239.99% |
| Cash from Operations | -48.95% | -494.56% | -592.12% | -259.57% | -273.50% |
| Capital Expenditure | 73.40% | 98.46% | 95.63% | 80.39% | 37.48% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 73.40% | 98.46% | 95.63% | 80.39% | 37.48% |
| Total Debt Issued | -95.97% | -73.21% | -69.87% | -78.82% | -80.30% |
| Total Debt Repaid | 95.11% | -210.00% | -250.00% | 95.13% | 95.02% |
| Issuance of Common Stock | 111.33% | 52,515.79% | 66,566.67% | 26,075.26% | 92,603.70% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 1,358.75% | 1,358.75% | -- | -- | -- |
| Cash from Financing | 93.02% | 469.14% | 31.24% | -19.71% | -27.57% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 97.20% | -288.32% | -155.69% | -169.28% | -132.49% |